Department of Dermatology, Yale University, New Haven, Connecticut; Department of Pathology, Yale University, New Haven, Connecticut.
Department of Dermatology, Yale University, New Haven, Connecticut; Department of Pathology, Yale University, New Haven, Connecticut.
J Am Acad Dermatol. 2017 Dec;77(6):1126-1132.e1. doi: 10.1016/j.jaad.2017.04.1119. Epub 2017 Jul 11.
Women with multiple squamous cell carcinomas (SCCs) of the legs have a striking clinical phenotype. Numerous tumors can develop in a short period of time.
Because histopathologic findings can vary in women with multiple SCC lesions, from keratoacanthoma-like to well-differentiated SCC, we hypothesized that TP53 variants might shed light on the appropriate classification.
We sequenced TP53 in 30 SCCs from 6 women who had multiple SCCs on their legs during a 21-month time frame.
Histopathologic analysis showed 16 of the 30 lesions did not have prominent cytologic atypia and were distinguished by having expanded follicle-like structures composed of large, glassy, eosinophilic keratinocytes; these lesions resembled keratoacanthoma and were categorized as keratoacanthoma-like squamous proliferations (KASPs). The 14 remaining tumors had more prominent cytologic atypia and remained classified as SCC. Twenty of 30 tumors (including the KASPs) from the 6 different patients lacked detectable TP53 mutations. Ten of the 14 tumors that remained classified as SCC had detectable TP53 mutations.
This is a small series.
These findings suggest that some cutaneous squamous proliferations on the legs of women with multiple lesions lack prominent cytologic atypia as well as TP53 mutations and might be more akin to keratoacanthoma than SCC or might represent a reactive phenomenon.
患有多发腿部鳞状细胞癌(SCC)的女性具有显著的临床表型。大量肿瘤可在短时间内形成。
由于多发 SCC 病变的女性患者的组织病理学发现可能有所不同,从角化棘皮瘤样到分化良好的 SCC,我们假设 TP53 变体可能有助于明确适当的分类。
我们对 6 名在 21 个月的时间内腿部多发 SCC 的女性的 30 个 SCC 进行了 TP53 测序。
组织病理学分析显示,30 个病变中有 16 个没有明显的细胞学异型性,其特征是扩大的滤泡样结构,由大的、玻璃状、嗜酸性角朊细胞组成;这些病变类似于角化棘皮瘤,被归类为角化棘皮瘤样鳞状增生(KASP)。其余 14 个肿瘤具有更明显的细胞学异型性,仍被归类为 SCC。来自 6 名不同患者的 30 个肿瘤(包括 KASP)中的 20 个缺乏可检测到的 TP53 突变。14 个仍被归类为 SCC 的肿瘤中有 10 个存在可检测到的 TP53 突变。
这是一个小系列。
这些发现表明,一些多发病变女性腿部的皮肤鳞状增生缺乏明显的细胞学异型性和 TP53 突变,可能更类似于角化棘皮瘤而非 SCC,或者可能代表一种反应性现象。